Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial

Research output: Contribution to journalJournal articleResearchpeer-review

Hans-dirk Düngen, Lars Kober, Savina Nodari, Morten Schou, Christiane Otto, Michael Becka, Friederike Kanefendt, Bernhard R. Winkelmann, Gunnar Gislason, Frank Richard, Olav Wendelboe Nielsen, Mihai Gheorghiade, Michele Senni

Original languageEnglish
JournalClinical Pharmacology in Drug Development
ISSN2160-763X
DOIs
Publication statusE-pub ahead of print - 2019

ID: 222245848